Skip to main content
Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.515
+0.215 (6.52%)
At close: Apr 28, 2026, 4:00 PM EDT
3.520
+0.005 (0.14%)
After-hours: Apr 28, 2026, 4:04 PM EDT

Alvotech Revenue

In the year 2025, Alvotech had annual revenue of $588.90M with 19.70% growth. Alvotech had revenue of $168.90M in the quarter ending December 31, 2025, with 10.14% growth.

Revenue (ttm)
$588.90M
Revenue Growth
+19.70%
P/S Ratio
1.88
Revenue / Employee
$460,441
Employees
1,279
Market Cap
1.10B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025588.90M96.93M19.70%
Dec 31, 2024491.98M398.60M426.84%
Dec 31, 202393.38M8.37M9.84%
Dec 31, 202285.02M45.33M114.23%
Dec 31, 202139.68M-29.77M-42.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
Evotec SE 925.65M
ANI Pharmaceuticals 883.37M
Tilray Brands 858.28M
Collegium Pharmaceutical 780.57M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Ironwood Pharmaceuticals 296.15M
Revenue Rankings

ALVO News

More News